Friedrich von Wintzingerode, PhD Genentech, Inc.

Friedrich is QC Lead of the iNeST (individualized Neoantigen Specific Therapy) program at Roche-Genentech.

Friedrich joined Roche-Genentech after earning his PhD in Microbiology and has over 20 years of experience in Quality Control and Quality Assurance in the biopharmaceutical industry, working on various topics including microbiological testing, material specifications, environmental monitoring, cleaning analytics, and analytics for release.

Friedrich has led several global technical teams (e.g. microbial identification, microbiological testing, endotoxin testing, and Low Endotoxin Recovery/LER) at Roche-Genentech and co-chaired the PDA LER Task Force, which authored PDA Technical Report No. 82.

Friedrich is vice chair of the PDA ATMP advisory board and member of the USP Microbiology Expert Committee.